Login to Your Account

NewCo News: With $50M in Hand, Hua Aims To License Drugs for China

By Trista Morrison

Thursday, October 13, 2011
Hua Medicine Ltd. made headlines last month with the news that it had raised $50 million in start-up funding from a blue-chip syndicate including Arch Venture Partners, Fidelity, Venrock, Sino-Alliance International Ltd. and WuXi PharmaTech Corporate Venture.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription